Developer docs
API playgroundTry for free, no card

Search company profiles

Multiwave Technologies

Full company profile

uuid00008ye

Namestring
Multiwave Technologies
Legal namestring
Multiwave Technologies AG
Websiteurl
multiwave.ch
Company typeenum
Private
Founded yearint
2015
Descriptiontext

Multiwave Technologies AG is a Geneva-based deep-technology company founded in 2015 by brothers Tryfon Antonakakis (PhD) and Panos Antonakakis, focused on portable magnetic resonance imaging. Its single commercial product, the MGNTQ, is an AI-powered, ultra-low field portable MRI scanner weighing just over 200 kg, designed to bring MRI to settings where conventional systems are uneconomic or impractical. The device combines proprietary metamaterial-based hardware and algorithms developed with Imperial College London, Institut Fresnel (CNRS/Aix-Marseille University), and Leiden University Medical Center with deep-learning methods for image segmentation and accelerated acquisitions. Use cases span ICU/emergency/intra-operative hospital imaging, rural and home-care settings, neonatal and infant imaging, and clinical research applications such as dementia, addictions, and hand/wrist imaging.

The company operates through wholly-owned subsidiaries in Geneva (headquarters), Marseille (R&D, since 2016, co-located with Institut Fresnel), and Lowell, Massachusetts (production, since 2025). Revenue today is generated primarily through research-grade device sales to academic medical centers and universities including Mount Sinai, Johns Hopkins, the University of Sussex, IMT Atlantique, and Aix-Marseille University via the A*Midex industrial Chair (5 devices, 2024-2027). Post-regulatory approval, Multiwave plans to shift to a subscription-based model to drive global deployment at a price point 5-10x below conventional MRI. Total capital raised since inception is CHF 23 million, split evenly between dilutive and non-dilutive sources, with the most recent $4.5M dilutive round led by Ava Investors in September 2025.

Commercially, Multiwave sells directly to enterprise customers via institutional tenders and research agreements, supported by reference customers at tier-one hospitals and an advisory board drawn from Imperial College London, Leiden University Medical Center, Aix-Marseille University, and major clinical institutions. The European Commission's Innovation Radar Prize and 2018 Best Young SME award, plus coverage in Forbes Greece in October 2025, provide external validation, while the recent recruitment of ex-Samsung Neurologica VP of Engineering Michael Limoli and the relocation of production to the US indicate preparation for scaled US commercialization.

Short descriptiontext

Multiwave Technologies builds the MGNTQ, an AI-powered, ultra-low field portable MRI scanner (~200 kg), targeting hospitals, underserved regions, neonatal and claustrophobic patients, and medical research institutions through direct sales and a planned subscription model.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersPlan-les-ouates, Switzerland
HQ citystring
Plan-les-ouates
HQ countrystring
Switzerland
HQ regionstring
Europe
Markets served

Serves global market

Offices3 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
portable MRI scanners, medical imaging devices, ultra-low field MRI, metamaterial technology, AI medical imaging
Industry1 code
PRIMARYHLAHABAL
Portable, Mobile & Point-of-Care Imaging Systems
Healthcare & Life Sciences/Medical Devices & Diagnostics/Medical Imaging & Radiology Equipment
NAICS code1 code
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
SIC code1 code
  • Electromedical & Electrotherapeutic Apparatus3845
Product category
Portable Medical Imaging Equipment
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model2 records
1Portable MRI Hardware Sales
TypeHardware Sales
Description

Sale of MGNTQ portable MRI scanners to healthcare providers and research institutions. Devices sold to hospitals, universities, and medical research centers for diagnostic and research applications.

multiwave.ch
2Subscription-Based Model
TypeSubscription Recurring
Description

Post-regulatory approval, Multiwave plans to offer a subscription-based model to facilitate global deployment of portable MRI scanners, providing recurring revenue from device access and services.

multiwave.ch
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Personnel, Supply Chain, Operations, Infrastructure
Pricing details2 tiers
1Portable MRI scanner at 5-10x lower cost than conventional MRI
ModelUnit PricingBilling cadenceMulti-year contract
Notes

MGNTQ is designed to be 5-10x more affordable than conventional MRI scanners. Specific pricing is not publicly disclosed.

multiwave.ch
2Subscription model for global deployment
ModelSubscriptionBilling cadenceAnnual
Notes

Post-regulatory approval subscription-based model planned to facilitate global deployment.

multiwave.ch
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Multiwave Technologies develops and sells the MGNTQ, an ultra-low field portable MRI scanner weighing just over 200kg. The AI-powered device is designed for mobility and affordability at 5-10x lower cost than conventional MRI scanners, enabling diagnostic and preventive imaging in settings where conventional MRI is not accessible, including hospitals (ICU, emergency, intra-operative care), rural areas, home care, retirement homes, and sporting events. The product leverages proprietary metamaterial algorithms and deep learning techniques for image segmentation and accelerated MRI acquisitions.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • 5-10x more affordable than conventional MRI scanners
+4 more records
Product overview1 text field

Multiwave Technologies is a science and technology innovator in metamaterials, artificial intelligence, and medical imaging. The company offers a single unified product: the MGNTQ portable MRI scanner, an ultra-low field mobile device designed to make MRI accessible globally. The MGNTQ is an AI-powered device weighing just over 200kg, intended for diagnostic and preventive care in circumstances where conventional MRI is not easily accessible. The company has pivoted from its original focus on metamaterial software to medical imaging innovation, leveraging its expertise in metamaterials and AI to develop portable imaging solutions.

Product and service1 record
1MGNTQ Portable MRI Scanner
CategoryMedical Imaging Hardware
Description

Ultra-low field portable MRI scanner weighing just over 200kg, designed for maximum mobility and affordability. AI-powered device for diagnostic and preventive care imaging where conventional MRI is not accessible. Targeted at healthcare providers and research institutions including hospitals, medical schools, and academic centers for applications in intensive care, emergency, intra-operative care, rural healthcare, dementia and neonatal research, and community imaging.

Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership10 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-01-01
Description

IMT Atlantique in Brest, France won a tender and agreed to purchase Multiwave's portable MRI for research in neo-natal imaging applications.

2A*Midex Foundation (Aix-Marseille University)
Strategic tierFlagshipTypeStrategic or Co-development PartnerAnnounced on2024-01-01
Description

The A*Midex Foundation of Aix-Marseille University and Multiwave signed a 4-year industrial Chair for medical imaging (2024-2027) with total program budget of €2.9 million. 5 portable MRI scanners to be delivered. Previously co-financed the Multiwave Chair (2021-2023) with €1.3 million budget.

multiwave.ch
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2024-01-01
Description

Johns Hopkins School of Medicine acquired Multiwave portable MRI scanner in 2024 to continue research on community imaging with a focus on addictions.

4Clinique de la Main Genève
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2024-01-01
Description

Strategic partnership to develop portable MRI for hand and wrist imaging applications.

multiwave.ch
5Leading MRI OEM
Strategic tierMinorTypeOEM/ Whitelabel/ Licensing PartnerAnnounced on2023-01-01
Description

A leading MRI original equipment manufacturer concluded a non-exclusive collaboration agreement with Multiwave in 2023 to conduct a feasibility study on the potential to adapt Multiwave's device for novel clinical applications.

multiwave.ch
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2022-07-01
Description

Mount Sinai Hospital New York concluded a partnership agreement with Multiwave in July 2022 to purchase a portable MRI scanner and conduct research on ultra-low field MRI. The scanner was later transferred to Johns Hopkins.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2022-01-01
Description

University of Sussex signed a master research agreement with Multiwave in 2022 to acquire Multiwave's portable MRI device to conduct research on monitoring dementia.

Strategic tierCoreTypeTechnology or IntegrationAnnounced on2018-01-01
Description

Multiwave partnered with Leiden University Medical Center in 2018 to apply its metamaterial design software on magnetic resonance imaging. Professor Andrew Webb serves as scientific advisor.

Strategic tierCoreTypeTechnology or IntegrationAnnounced on2016-01-01
Description

Multiwave partnered with Imperial College London in 2016 to develop metamaterial algorithms. Co-founder Tryfon Antonakakis completed PhD in applied mathematics at Imperial College and worked there as post-doctoral research associate.

Strategic tierFlagshipTypeTechnology or IntegrationAnnounced on2016-01-01
Description

Multiwave created a wholly-owned R&D subsidiary in France and partnered with Institut Fresnel, a joint lab of CNRS and Aix-Marseille University, to develop next-generation metamaterials for medical imaging. Multiple employees and researchers from Institut Fresnel joined or collaborate with Multiwave.

Recent move8 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Hyperfine is the closest direct competitor — it has developed and FDA-cleared the Swoop portable MRI scanner, pursuing the same category Multiwave targets with MGNTQ. Both companies aim to bring MRI to bedside and underserved settings using low-field, low-cost, AI-enabled hardware.

TypeBroad incumbent
Description

Global MRI incumbent with a broad portfolio of 1.5T/3T systems and a deep installed base in hospitals. Comparable as the established category leader that any portable MRI disruptor must displace, and a likely OEM/licensing counterparty for Multiwave.

TypeBroad incumbent
Description

Major MRI incumbent with deep clinical channel relationships and a wide product range across imaging modalities. Relevant as both a competitive threat in portable imaging and a potential strategic partner for distribution.

TypeBroad incumbent
Description

Diversified imaging OEM with broad MRI and patient monitoring offerings. Comparable as an incumbent with the service, regulatory, and hospital procurement relationships that any portable MRI entrant must leverage or compete against.

TypeBroad incumbent
Description

Samsung subsidiary that pioneered mobile CT (CereTom, BodyTom) and is a natural analogue for portable imaging. Directly comparable given Multiwave's recent hire of ex-Samsung Neurologica VP Engineering and the board presence of former Samsung/Neurologica executives.

TypeEmerging player
Description

Developer of compact, dedicated MRI systems (notably for neonatal/infant imaging in NICU settings) that overlap with Multiwave's portable, low-acoustic use case. Relevant as a niche competitor focused on similar patient populations (neonates, ICU).

TypeEmerging player
Description

Neuro-focused imaging and surgical visualization company with compact MRI and AI-driven imaging tools. Comparable as a smaller specialty player combining hardware and AI software to address clinical neurology workflows — overlapping with Multiwave's research use cases at Johns Hopkins and Sussex.

TypeBroad incumbent
Description

Diversified imaging OEM (MRI, CT, ultrasound) with global hospital reach. Comparable as an incumbent that could leverage distribution scale to counter or acquire portable MRI entrants.

TypeBroad incumbent
Description

Imaging OEM with MRI and mobile imaging offerings, including point-of-care and bedside solutions. Comparable as an incumbent pursuing accessible imaging — relevant strategic adjacency to Multiwave's portability thesis.

TypeBroad incumbent
Description

Global MRI/CT OEM with rapidly expanding presence in developed and emerging markets and a broad product portfolio. Comparable as an incumbent increasingly competing on price and accessibility — directly aligned with Multiwave's emerging-market thesis.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks7 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers6 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability4 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles26 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries2 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds19 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors8 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Multiwave Technologies

Portable Medical Imaging Equipmentmultiwave.ch

Multiwave Technologies builds the MGNTQ, an AI-powered, ultra-low field portable MRI scanner (~200 kg), targeting hospitals, underserved regions, neonatal and claustrophobic patients, and medical research institutions through direct sales and a planned subscription model.

What Multiwave Technologies does

Multiwave Technologies AG is a Geneva-based deep-technology company founded in 2015 by brothers Tryfon Antonakakis (PhD) and Panos Antonakakis, focused on portable magnetic resonance imaging. Its single commercial product, the MGNTQ, is an AI-powered, ultra-low field portable MRI scanner weighing just over 200 kg, designed to bring MRI to settings where conventional systems are uneconomic or impractical. The device combines proprietary metamaterial-based hardware and algorithms developed with Imperial College London, Institut Fresnel (CNRS/Aix-Marseille University), and Leiden University Medical Center with deep-learning methods for image segmentation and accelerated acquisitions. Use cases span ICU/emergency/intra-operative hospital imaging, rural and home-care settings, neonatal and infant imaging, and clinical research applications such as dementia, addictions, and hand/wrist imaging.

The company operates through wholly-owned subsidiaries in Geneva (headquarters), Marseille (R&D, since 2016, co-located with Institut Fresnel), and Lowell, Massachusetts (production, since 2025). Revenue today is generated primarily through research-grade device sales to academic medical centers and universities including Mount Sinai, Johns Hopkins, the University of Sussex, IMT Atlantique, and Aix-Marseille University via the A*Midex industrial Chair (5 devices, 2024-2027). Post-regulatory approval, Multiwave plans to shift to a subscription-based model to drive global deployment at a price point 5-10x below conventional MRI. Total capital raised since inception is CHF 23 million, split evenly between dilutive and non-dilutive sources, with the most recent $4.5M dilutive round led by Ava Investors in September 2025.

Commercially, Multiwave sells directly to enterprise customers via institutional tenders and research agreements, supported by reference customers at tier-one hospitals and an advisory board drawn from Imperial College London, Leiden University Medical Center, Aix-Marseille University, and major clinical institutions. The European Commission's Innovation Radar Prize and 2018 Best Young SME award, plus coverage in Forbes Greece in October 2025, provide external validation, while the recent recruitment of ex-Samsung Neurologica VP of Engineering Michael Limoli and the relocation of production to the US indicate preparation for scaled US commercialization.

Multiwave Technologies firmographics

Firmographics
Name
Multiwave Technologies
Legal name
Multiwave Technologies AG
Website
https://multiwave.ch
Company type
Private
Founded year
2015
Operating status
Operating
Headcount range
11–50 employees
Short description
Multiwave Technologies builds the MGNTQ, an AI-powered, ultra-low field portable MRI scanner (~200 kg), targeting hospitals, underserved regions, neonatal and claustrophobic patients, and medical research institutions through direct sales and a planned subscription model.
Ownership category
akta.pro rank

Multiwave Technologies industry classification

Industry
Product category
Portable Medical Imaging Equipment
NAICS
Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)
SIC
Electromedical & Electrotherapeutic Apparatus (3845)
akta.pro industry
PRIMARYHLAHABAL
Portable, Mobile & Point-of-Care Imaging Systems
Healthcare & Life Sciences/Medical Devices & Diagnostics/Medical Imaging & Radiology Equipment

Keywords

  • Portable MRI scanners
  • Medical imaging devices
  • Ultra-low field MRI
  • Metamaterial technology
  • AI medical imaging

Where Multiwave Technologies is headquartered

Location

Headquarters

HQ city
Plan-les-ouates
HQ country
Switzerland
HQ region
Europe

Offices3 records

Markets served

Multiwave Technologies business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Personnel, Supply Chain, Operations, Infrastructure

Revenue model

  1. Portable MRI Hardware Sales: Sale of MGNTQ portable MRI scanners to healthcare providers and research institutions. Devices sold to hospitals, universities, and medical research centers for diagnostic and research applications.
  2. Subscription-Based Model: Post-regulatory approval, Multiwave plans to offer a subscription-based model to facilitate global deployment of portable MRI scanners, providing recurring revenue from device access and services.

Pricing tiers

ModelBillingPrice
Unit PricingMulti-year contractPortable MRI scanner at 5-10x lower cost than conventional MRI
SubscriptionAnnualSubscription model for global deployment

Go-to-market motion1 record

Distribution channels3 records

Marketing channels5 records

Multiwave Technologies product offering

Product offering

Core offering

Multiwave Technologies develops and sells the MGNTQ, an ultra-low field portable MRI scanner weighing just over 200kg. The AI-powered device is designed for mobility and affordability at 5-10x lower cost than conventional MRI scanners, enabling diagnostic and preventive imaging in settings where conventional MRI is not accessible, including hospitals (ICU, emergency, intra-operative care), rural areas, home care, retirement homes, and sporting events. The product leverages proprietary metamaterial algorithms and deep learning techniques for image segmentation and accelerated MRI acquisitions.

Product overview

Multiwave Technologies is a science and technology innovator in metamaterials, artificial intelligence, and medical imaging. The company offers a single unified product: the MGNTQ portable MRI scanner, an ultra-low field mobile device designed to make MRI accessible globally. The MGNTQ is an AI-powered device weighing just over 200kg, intended for diagnostic and preventive care in circumstances where conventional MRI is not easily accessible. The company has pivoted from its original focus on metamaterial software to medical imaging innovation, leveraging its expertise in metamaterials and AI to develop portable imaging solutions.

Differentiator

Problem solved

Functional benefit

Products and services

  • MGNTQ Portable MRI Scanner Ultra-low field portable MRI scanner weighing just over 200kg, designed for maximum mobility and affordability. AI-powered device for diagnostic and preventive care imaging where conventional MRI is not accessible. Targeted at healthcare providers and research institutions including hospitals, medical schools, and academic centers for applications in intensive care, emergency, intra-operative care, rural healthcare, dementia and neonatal research, and community imaging.

Quantifiable outcome

  • 5-10x more affordable than conventional MRI scanners
  • +4 more outcomes

Companies that use Multiwave Technologies

Customer profile

Named customers6 records

Segments4 records

Ideal customer profiles4 records

Multiwave Technologies technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability4 records

Feature4 records

Multiwave Technologies partnerships and signals

Strategic signal

Partnerships

Ten partnerships are on record, tiered core, flagship and minor.

  • IMT AtlantiquecoreStrategic or Co-development Partner · 1 January 2025IMT Atlantique in Brest, France won a tender and agreed to purchase Multiwave's portable MRI for research in neo-natal imaging applications.
  • A*Midex Foundation (Aix-Marseille University)flagshipStrategic or Co-development Partner · 1 January 2024The A*Midex Foundation of Aix-Marseille University and Multiwave signed a 4-year industrial Chair for medical imaging (2024-2027) with total program budget of €2.9 million. 5 portable MRI scanners to be delivered. Previously co-financed the Multiwave Chair (2021-2023) with €1.3 million budget.
  • Johns Hopkins School of MedicinecoreStrategic or Co-development Partner · 1 January 2024Johns Hopkins School of Medicine acquired Multiwave portable MRI scanner in 2024 to continue research on community imaging with a focus on addictions.
  • Clinique de la Main GenèvecoreStrategic or Co-development Partner · 1 January 2024Strategic partnership to develop portable MRI for hand and wrist imaging applications.
  • Leading MRI OEMminorOEM/ Whitelabel/ Licensing Partner · 1 January 2023A leading MRI original equipment manufacturer concluded a non-exclusive collaboration agreement with Multiwave in 2023 to conduct a feasibility study on the potential to adapt Multiwave's device for novel clinical applications.
  • Mount Sinai Hospital New YorkcoreStrategic or Co-development Partner · 1 July 2022Mount Sinai Hospital New York concluded a partnership agreement with Multiwave in July 2022 to purchase a portable MRI scanner and conduct research on ultra-low field MRI. The scanner was later transferred to Johns Hopkins.
  • University of Sussex (Brighton & Sussex Medical School)coreStrategic or Co-development Partner · 1 January 2022University of Sussex signed a master research agreement with Multiwave in 2022 to acquire Multiwave's portable MRI device to conduct research on monitoring dementia.
  • Leiden University Medical CentercoreTechnology or Integration · 1 January 2018Multiwave partnered with Leiden University Medical Center in 2018 to apply its metamaterial design software on magnetic resonance imaging. Professor Andrew Webb serves as scientific advisor.
  • Imperial College LondoncoreTechnology or Integration · 1 January 2016Multiwave partnered with Imperial College London in 2016 to develop metamaterial algorithms. Co-founder Tryfon Antonakakis completed PhD in applied mathematics at Imperial College and worked there as post-doctoral research associate.
  • Institut Fresnel (CNRS/Aix-Marseille University)flagshipTechnology or Integration · 1 January 2016Multiwave created a wholly-owned R&D subsidiary in France and partnered with Institut Fresnel, a joint lab of CNRS and Aix-Marseille University, to develop next-generation metamaterials for medical imaging. Multiple employees and researchers from Institut Fresnel joined or collaborate with Multiwave.

Scale indicators5 records

Recent moves8 records

Expansion highlights6 records

Multiwave Technologies competitors and assessment

Company assessment

Direct peers

  • Hyperfine: Hyperfine is the closest direct competitor — it has developed and FDA-cleared the Swoop portable MRI scanner, pursuing the same category Multiwave targets with MGNTQ. Both companies aim to bring MRI to bedside and underserved settings using low-field, low-cost, AI-enabled hardware.

Broad incumbents

  • Siemens Healthineers: Global MRI incumbent with a broad portfolio of 1.5T/3T systems and a deep installed base in hospitals. Comparable as the established category leader that any portable MRI disruptor must displace, and a likely OEM/licensing counterparty for Multiwave.
  • GE HealthCare: Major MRI incumbent with deep clinical channel relationships and a wide product range across imaging modalities. Relevant as both a competitive threat in portable imaging and a potential strategic partner for distribution.
  • Philips Healthcare: Diversified imaging OEM with broad MRI and patient monitoring offerings. Comparable as an incumbent with the service, regulatory, and hospital procurement relationships that any portable MRI entrant must leverage or compete against.
  • Samsung Neurologica: Samsung subsidiary that pioneered mobile CT (CereTom, BodyTom) and is a natural analogue for portable imaging. Directly comparable given Multiwave's recent hire of ex-Samsung Neurologica VP Engineering and the board presence of former Samsung/Neurologica executives.
  • Canon Medical Systems: Diversified imaging OEM (MRI, CT, ultrasound) with global hospital reach. Comparable as an incumbent that could leverage distribution scale to counter or acquire portable MRI entrants.
  • Fujifilm Healthcare: Imaging OEM with MRI and mobile imaging offerings, including point-of-care and bedside solutions. Comparable as an incumbent pursuing accessible imaging — relevant strategic adjacency to Multiwave's portability thesis.
  • United Imaging Healthcare: Global MRI/CT OEM with rapidly expanding presence in developed and emerging markets and a broad product portfolio. Comparable as an incumbent increasingly competing on price and accessibility — directly aligned with Multiwave's emerging-market thesis.

Emerging players

  • Aspect Imaging: Developer of compact, dedicated MRI systems (notably for neonatal/infant imaging in NICU settings) that overlap with Multiwave's portable, low-acoustic use case. Relevant as a niche competitor focused on similar patient populations (neonates, ICU).
  • Synaptive Medical: Neuro-focused imaging and surgical visualization company with compact MRI and AI-driven imaging tools. Comparable as a smaller specialty player combining hardware and AI software to address clinical neurology workflows — overlapping with Multiwave's research use cases at Johns Hopkins and Sussex.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks7 records

Key highlights7 records

Customer concentration

Multiwave Technologies social profiles

Digital presence

Multiwave Technologies financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Multiwave Technologies leadership team

Management profile

Number of profiles

Profiles26 records

Multiwave Technologies subsidiaries and ownership

Company hierarchy

Subsidiaries2 records

Multiwave Technologies funding detail

Funding detail

Funding overview

Funding rounds19 records

Investors8 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Multiwave Technologies M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Multiwave Technologies

What does Multiwave Technologies do?

Multiwave Technologies develops and sells the MGNTQ, an ultra-low field portable MRI scanner weighing just over 200kg. The AI-powered device is designed for mobility and affordability at 5-10x lower cost than conventional MRI scanners, enabling diagnostic and preventive imaging in settings where conventional MRI is not accessible, including hospitals (ICU, emergency, intra-operative care), rural areas, home care, retirement homes, and sporting events. The product leverages proprietary metamaterial algorithms and deep learning techniques for image segmentation and accelerated MRI acquisitions.

Is Multiwave Technologies a public or private company?

Multiwave Technologies is a private company. It is classified as venture growth investor backed and is currently operating.

When was Multiwave Technologies founded?

Multiwave Technologies was founded in 2015. It employs 11 to 50 people.

Where is Multiwave Technologies based?

Multiwave Technologies is headquartered in Plan-les-ouates, Switzerland, in the Europe region.

How does Multiwave Technologies make money?

Two revenue lines are on record. Portable MRI Hardware Sales are the primary driver. The others are subscription-Based Model.

Who are Multiwave Technologies's main competitors?

Hyperfine is listed as a direct peer. Broad incumbents are Siemens Healthineers, GE HealthCare, Philips Healthcare, Samsung Neurologica, Canon Medical Systems, Fujifilm Healthcare and United Imaging Healthcare. Emerging players are Aspect Imaging and Synaptive Medical.

Does Multiwave Technologies have an API?

No public API is recorded for Multiwave Technologies.

What industry is Multiwave Technologies in?

Multiwave Technologies's product category is Portable Medical Imaging Equipment. Its primary akta.pro industry code is HLAHABAL, Portable, Mobile & Point-of-Care Imaging Systems. Its NAICS code is 334510 and its SIC code is 3845.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
BioAlpsMultiwave Technologies Secures CHF 3.6M and Expand Operations in the USGeneva-based Multiwave Technologies AG has raised CHF 3.6 million (USD 4.5 million) in fresh funding from senior US healthcare executives, a Geneva-based clinic, a former Director of the London Mathematical Laboratory, and Ava Investors, which increased its stake following an initial investment in 2023. The funding, completed across 2024 and 2025, will accelerate the development and FDA 510(k) clearance of its portable MRI device MGNTQ™ and support the establishment of a new assembly plant in Lowell, Massachusetts, with a commercial launch planned for 2026 in the United States.startupticker.chMultiwave secures CHF 3.6 million and launches US operations in BostonGeneva-based Multiwave Technologies AG has raised CHF 3.6m (USD 4.5m) in funding across 2024 and 2025 from senior US healthcare executives, a Geneva-based clinic, an ex-Director of the London Mathematical Laboratory, and Geneva-based investment firm Ava Investors. The proceeds will fund FDA 510(k) clearance for the company's portable MRI device MGNTQ, with a commercial US launch planned for 2026. The company is establishing a new global assembly facility in Lowell, Massachusetts, while maintaining operations in Geneva and Marseille.startupticker.chMultiwave attracts new fundsMultiwave Technologies AG reported that its three portfolio companies raised funding, secured customers, and acquired a Dutch firm. The group has raised CHF 4.5M from angel investors and CHF 7.2M in nondilutive capital. Subsidiaries are pursuing further fundraising, including a CHF 1M round for Multiwave Metacrystal.Le FigaroDes métamatériaux pour des IRM du cerveau plus précisesResearchers tested metamaterials in a 7T MRI on a healthy volunteer, improving image resolution to 0.2mm. The low-cost copper-based materials reduce exposure time and could enable early disease detection. The M-Cube project, funded by the EU, aims to bring this technology to clinical use.startupticker.chMultiwave part of a consortium awarded a € 3.9 million European Union grantThe M-CUBE project, a consortium including Swiss company Multiwave, was awarded a €3.9 million EU grant for a four-year MRI antenna research program. The project aims to improve spatial and temporal resolution in high-field MRI using passive metamaterial structures, enabling earlier disease detection.